研究文章
个性化的肉瘤保健的影响(PERSARC)预测模型在临床决策中多学科设置
|
|
没有PERSARC,N(%) |
PERSARC,N(%) |
|
| 新辅助放疗 |
| 手术R0 |
10 (27.7%) |
25 (69.4%) |
| 手术R1 |
13 (36.1%) |
6 (16.7%) |
| 手术R2 |
2 (5.6%) |
0 (0.0%) |
|
| 手术 |
| 截肢 |
5 (13.8%) |
1 (2.8%) |
| R0 |
2 (5.6%) |
1 (2.8%) |
| R1 |
1 (2.8%) |
3 (8.3%) |
| R2 |
2 (5.6%) |
0 (0.0%) |
|
| 辅助放疗 |
| 手术R0 |
0 (0.0%) |
0 (0.0%) |
| 手术R1 |
1 (2.8%) |
0 (0.0%) |
| 手术R2 |
0 (0.0%) |
0 (0.0%) |
|
|
